Venture Life Group (LON:VLG) Hits New 1-Year High – Here’s Why
by Michael Walen · The Markets DailyShares of Venture Life Group plc (LON:VLG – Get Free Report) reached a new 52-week high during trading on Monday . The company traded as high as GBX 68 and last traded at GBX 66.72, with a volume of 341852 shares changing hands. The stock had previously closed at GBX 67.50.
Venture Life Group Price Performance
The company has a quick ratio of 1.48, a current ratio of 2.22 and a debt-to-equity ratio of 28.45. The company has a market capitalization of £84.51 million, a P/E ratio of -87.79, a P/E/G ratio of 5.67 and a beta of 0.30. The company’s 50-day simple moving average is GBX 61.41 and its 200 day simple moving average is GBX 58.80.
Insiders Place Their Bets
In other Venture Life Group news, insider Jerry Randall sold 387,705 shares of the business’s stock in a transaction dated Friday, January 9th. The shares were sold at an average price of GBX 66, for a total value of £255,885.30. 6.86% of the stock is owned by corporate insiders.
About Venture Life Group
Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the global self-care market.
With operations in the UK, The Netherlands and Italy, the Group’s product portfolio includes some key products such as the UltraDEX and Dentyl oral care product ranges, food supplements for maintaining brain function, medical devices for women’s intimate healthcare, fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies and grocery multiples.